Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : Ad5.F35-hGCC-PADRE, an adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE, expresses both the extracellular domain of human guanylate cyclase C (GCC1-430) as well as the unique synthetic CD4+ T-cell epitope called PADRE.
Product Name : Ad5.F35-hGCC-PADRE
Product Type : Vaccine
Upfront Cash : Undisclosed
November 30, 2022
Reset All
